RecruitingNCT06733740

Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma

The Clinical Outcomes of Ultrasound-guided Thermal Ablation for the Treatment of Papillary Thyroid Carcinoma: A Multicenter Study


Sponsor

Chinese PLA General Hospital

Enrollment

3,000 participants

Start Date

Dec 10, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

To evaluate long-term outcomes of ultrasound-guided thermal ablation for the treatment of papillary thyroid carcinoma


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing ultrasound-guided thermal ablation — a minimally invasive procedure that uses heat to destroy tumor tissue — as a treatment for small papillary thyroid carcinoma (a common and usually slow-growing type of thyroid cancer), as an alternative to surgery. **You may be eligible if...** - You are 18–80 years old - You have been diagnosed with papillary thyroid carcinoma confirmed by biopsy - Your tumor is 2 cm or smaller - There is no evidence that the cancer has spread beyond the thyroid (no extension into surrounding tissue, lymph node involvement, or distant spread) on imaging - You have had at least 12 months of follow-up **You may NOT be eligible if...** - Your cancer shows aggressive features or is a different type of thyroid cancer - You have a history of radiation to your neck - You have a blood clotting disorder or serious heart, breathing, liver, or kidney problems - You have paralysis of the vocal cord on the opposite side of the tumor Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREultrasound-guided thermal ablation

ultrasound-guided thermal ablation to treat tumor


Locations(1)

Chinese PLA General Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06733740


Related Trials